Skip to main content
logo
Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.740
-0.020 (-0.72%)
At close: Jan 29, 2026, 4:00 PM EST
2.620
-0.120 (-4.38%)
After-hours: Jan 29, 2026, 4:05 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Oncolytic Immunotherapies
8.00K
Log In
Log In
Oncolytic Immunotherapies Growth
-95.29%
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States
8.00K
Log In
Log In
United States Growth
-95.29%
Log In
Log In